Received Nov 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 47d3s | RA |
Mal administration/58 yr old female patient received pediatric hep b instead of adult; 58 yr old female patient received pediatric hep b instead of adult; This non-serious case was reported by a other health professional via sales rep and described the occurrence of adult use of a child product in a 58-year-old female patient who received HBV (Engerix B pediatric) (batch number 47d3s) for prophylaxis. On 09-SEP-2025, the patient received Engerix B pediatric (right deltoid). On 09-SEP-2025, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: Mal administration/58 yr old female patient received pediatric hep b instead of adult) and underdose (Verbatim: 58 yr old female patient received pediatric hep b instead of adult). The outcome of the adult use of a child product and underdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 29-Oct-2025 The patient received pediatric Hepatitis B instead of adult.